This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Dexlansoprazole
DEXILANT, DEXLANSOPRAZOLE, KAPIDEX – TAKEDA CANADA INC (NOC Search)
Patents:
- 2463690: APOTEX
- 2499574: APOTEX
- 2570916: APOTEX
- 2671369: APOTEX
- 2702356: APOTEX
- 2737851: APOTEX
- 2771725: APOTEX
Unknown/Other
- PM(NOC) – A-9-12 (2013 FCA 13) – T-2044-10 (2011 FC 1444)
APOTEX
- PM(NOC) – T-151-22 (2023 FC 63, 2024 FC 106, 2023 FC 1353, 2023 FC 1366) – T-2034-22
Return to the Patented Medicine Litigation page.